CLINICAL_TRIALS
trial_result
· 2023-10-12
Clinical Trial Update: Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema [Phase 2]
Summary
Phase 2 study evaluating multiple-dose safety and efficacy of LKA651 in diabetic macular edema; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2023-10-12